General Information
 Committees
 Secretariat Addresses
 CME Accreditation
 Programme at-a-glance
 Scientific Programme
 Registration
 Accommodation
 Poster Presentations
 Congress home page
 About Stresa
 Convention Location
 Exhibition area
 Excursions
 Acknowledgements
 Back to EAPC home page
   
 
 
Saturday, 5 June 2004
 

 POSTER DISPLAY
 Ethics
ID
 Title/Author
200
 What to do when patients request for euthanasia in Palliative Care?
 H.C. Muller-Busch (Germany)
201
 Nurses' involvement in the care process for patients requesting euthanasia
 N. De Bal (Belgium)
202
 The Methodology of Empirical Ethics: using Reflective Equilibrium
 to study Ethical Problems concerning Palliative Chemotherapy

 S. de Kort (Netherlands)
203
 Attitudes of Dutch physicians and the general public towards
 end-of-life decisions

 J. Rietjens (Netherlands)
204
 Ethical Decision Making in End of Life Care - An exploration
 of nurses' experiences

 A.M. Lynch (Ireland)
205
 The influence of religious attitudes of general practitioners
 on their ethical maturity, moral competence and end-of-life interventions

 M. Vermeulen (Belgium)
206
 Religion and ethics at the end of life. the case of elderly Moroccans
 in antwerp, Belgium

 S. Van den Branden (Belgium)
207
 Ethics and Statistics A Population-based Nationwide Study on Parents'
 Perception of a Questionnaire on Their Child's Death in Cancer

 U. Kreicbergs (Sweden)
 Other
ID
 Title/Author
208
 Effectiveness of a hospital Palliative Care team in improving prescribing
 practice in the management of cancer pain: compliance/violation
 of National guidelines (SIGN 44)

 K. Sherry (United Kingdom)
209
 Palliative home care increases the rate of dying at home
 J. Papke (Germany)
210
 Development of a Handbook of Practical Research Tips
 D. Waterman (United Kingdom)
211
 An evaluation of a palliative care course for registered general
 nurses using the palliative care quiz for nursing (PCQN)

 H. Smyth (Ireland)
212
 Death Education-Beyond the Classroom Walls: Analysis of
 Clinical Telephone Supervision

 B. Dane (United States)
213
 Evaluating a community nurse palliative care educational programme:
 the views of family doctors

 C. Shipman (United Kingdom)
214
 A UK survey to determine the prevalence of complementary therapy
 use in men with prostate cancer

 S. Farrelly (United Kingdom)
215
 An exploration looking at the perspective of volunteers
 in Palliative Care day services

 R. Perry (United Kingdom)
216
 Do psychogeriatric nursing home patients suffer from
 artificial nutrition or hydration?

 P.T. van Wigcheren (Netherlands)
217
 Patients' attitudes towards end-of-life decisions: longitudinal data
 A. van der Heide (Netherlands)
218
 Is social support related to coping with stress and levels of anxiety
 and depression in terminal cancer patients?

 G.I. Ringdal (Norway)
219
 Multicenter nursing research group. Subcutaneous administration:
 Practices of Palliative Care nursing in Catalonia (Spain)

 E. Corrales (Spain)
220
 Do we meet learning preferences of physicians in palliative care courses?
 B. Fittkau-Tönnesmann (Germany)
221
 A new way for basic training in palliative care
 G. Gremaud (Switzerland)
222
 The patient-other dynamics of the decision to forgo or stop
 active treatment for cancer

 L. Kacen (Israel)
 Policy and Organisation
ID
 Title/Author
223
 Audit of End of Life Decisions in Chronic Neurological Illness
 L. Ferguson (United Kingdom)
224
 The Family Doctor's Perspective of a Palliative Home Care Service
 G. Tracey (Ireland)
225
 What are the difficulties with Continuing Professional Development (CPD)
 in Palliative Medicine?

 M. Lloyd-Williams (United Kingdom)
226
 Does Education make a difference to Service Improvement?
 Interim Evaluation results from the Yorkshire Cancer Network (YCN)
 District Nurse Palliative Education Project

 V.W. Dunn (United Kingdom)
227
 The assessment by GP's of the development of regional networks
 in Palliative Care in the Netherlands

 W.J.J. Jansen (Netherlands)
228
 An evaluation of a new specialist physiotherapy service
 for Palliative Care inpatients

 J. Elsmore (United Kingdom)
229
 Palliative Care provision and policy in twelve countries
 of eastern Europe and central Asia

 M. Wright (United Kingdom)
230
 Effects of an Advanced Illness Care Coordination Program on Patient-
 Provider Communication, Patient Satisfaction, and Support of Surrogates

 R. Toseland (United States)
231
 Living alone and dying at home
 E. Gyllenhammar (Sweden)
232
 Equipment for domiciliary care: a quality service
 B. Rizzi (Italy)
233
 Methodology for palliative care research: evaluating Palliative Care
 & aged care policy using discourse analysis

 M. O'Connor (Australia)
234
 Collaborating with a specialised Palliative home Care team:
 district Nurses' and GPs' point of view

 D. Goldschmidt (Denmark)
235
 A comparison between telephone and bedside consultations given
 by Dutch Palliative Care Consultation (PCC) teams:
 results from a nationwide registration

 V. Scrhijnemaekers (Netherlands)
236
 Quality end-of-life care in long term care facilities:
 Service providers' perspective

 K. Brazil (Canada)
237
 Towards improving the coordination of supportive cancer care
 services in the community

 K. Brazil (Canada)
238
 Hospice care at home - evaluation of a 18 months pilot study
 T. van Iersel (Belgium)
240
 Is access to community nursing for palliative care patients equitable?
 J. Burt (United Kingdom)
241
 DNR-policy in hospitals and on acute geriatric units in Flanders, Belgium
 C. De Gendt (Belgium)
242
 Places of death in Geneva Switzerland from 1970 to 2000:
 Evolutions, determinants and social implications

 M.E. Kabengele (Switzerland)
243
 Financial pain: palliative care services and financial advice
 A. Quinn (United Kingdom)
244
 Old and given up for dying - Palliative care in Nursing Homes
 B.S. Husebø (Norway)
245
 Determining patient related factors on resource utilisation: a preliminary
 patient based casemix costing analysis in community Palliative Care

 A. Welshman (Italy)
246
 Place of death of cancer patients: analysis of the impact of the activity
 of a Palliative Care Network

 C. Peruselli (Italy)
247
 The paradigm of Palliative Care in oncology from the perspective
 of quality of life

 J. Shevchenko (Russia)
248
 The practice of Palliative Care
 T. Drumond (Brazil)
249
 Continuity of care for terminally ill by Palliative Support Teams
 in general hospitals

 R. Verbinnen (Belgium)
250
 Good practice in palliative care (PC), palliative medicine (PM)
 and terminal care (TC) according to medical doctors (MDs), nurses
 and psychologists working in a Palliative Support Team (PST)

 R. Verbinnen (Belgium)
251
 Effectiveness in control symptom in palliative care services in Spain
 R. Roca (Spain)
253
 Evaluation of mobile Palliative Care teams in Mecklenburg-Vorpommern
 (Germany)

 W. Diemer (Germany)
254
 The role of education and research in the development of Palliative Care
 in Łódź province in Polandre

 W. Leppert (Poland)
255
 Implementing a Palliative Care Consult Team Within an Intensive Care Unit
 S. Radwany (United States)
256
 The role of local networks in the development of Palliative Care
 A. Visser (Netherlands)
257
 Physical Exercise and Rehabilitation among Cancer Patients
 L. Oldervoll (Norway)
258
 The "Research Centre" of Italian Observatory for Palliative Care (OICP):
 model, organisation and activities

 O. Corli (Italy)
259
 Outcomes and patient spectrum of an interdisciplinary Palliative Care
 Hospital Support Team at a university hospital

 M. Gockel (Germany)
260
 Palliative Care policy development in Hungary (2003-2004)
 K.Hegedus (Hungary)
261
 Working together in palliative care: a matter of building bridges?
 B. Van den Eynden (Belgium)
262
 The observation of the installing of a syringe driver MS26
 in a Palliative Care setting

 B. Van den Eynden (Belgium)
263
 Experiences of Implementation of a Palliative Care Team Service
 in a University Hospital

 J. Verebes (Austria)
264
 "Palliative Care in Albania" Prospect for the future
 A. Sallaku (Albania)
265
 Promoting the developement and integration of palliative care mobile
 support teams in the hospital, research findings from an European
 collaboration

 C. Markstein (Belgium)
266
 Palliative Day Care in Belgium: from terminal care towards care
 for incurable patients

 W. Distelmans (Belgium)
267
 A comparison of quality-systems in palliative care in the Netherlands
 A. Rhebergen (Netherlands)
268
 Non-oncologic Palliative Care in terminal cardio-pulmonary patients
 M. Lusuardi (Italy)
 Symptoms
ID
 Title/Author
269
 A survey of practice in malignant ascites discussed in relation
 to findings from a systematic review of the literature

 N. Preston (United Kingdom)
270
 A prospective study to compare three depression screening tools
 in patients who are terminally ill

 M. Lloyd-Williams (United Kingdom)
271
 Efficacy of Laxative Management in Palliative Care Patients:
 is Polyethylene Glycol a New Option?

 S. Wirz (Germany)
272
 Opioid Dose Titration for Severe Cancer Pain: A Systematic Evidence
 Based Review

 M.P. Davis (United States)
273
 Frequency and reasons for opioid rotation in Palliative Care -
 a prospective study

 H.C. Muller-Busch (Germany)
274
 Symptoms and Characteristics of Terminally Ill Nursing Home Patients
 H. Brandt (Netherlands)
275
 Sedation for patients (PTS) with advanced cancer followed by
 a Palliative Care unit: a study in Turin

 F. Cancelli (Italy)
276
 Suicide frequency in PCU, a prospective french study
 M. Filbet (France)
277
 Morphine use in cancer pain: from 'last resort' to 'gold standard'
 J. Seymour (United Kingdom)
278
 Does a medication of trans-dermal fentanyl influence postoperative
 pain management after palliative surgery?

 H.C. Wartenberg (Germany)
279
 A Dose Titration Study of Thalidomide in Cancer Anorexia
 M.P. Davis (United States)
280
 Personal values, individual quality of life, and psychosocial symptoms
 in Palliative Care patients

 M. Fegg (Germany)
281
 BPI and EuroQol-5D as indicators of efficiency with Zoledronic
 acid treatment in cancer

 J.C. Torrent (Spain)
282
 Ventilatory function with the use of parenteral opioids in advanced cancer
 M.P. Davis (United States)
283
 Usage of SSRI group in codeine resistant cough
 F. Blaszczyk (Poland)
284
 Measuring signs and symptoms of imminently dying in home
 cancer patients

 F. Bodini (Italy)
285
 Multiple related pain problems in patients referred to dutch Palliative Care
 consultation teams

 L. van Zuylen (Netherlands)
286
 Utility of the brief pain inventory. negative pain management index
 and its predictors: the russian experience

 J. Shevchenko, A. Novik, K. Lyadov (Russia)
287
 To analyse prognostic factors of answer to the radiotherapy in malignant
 spinal cord compression (MSCC) in Palliative patients

 G.S. Bermudez (Spain)
288
 ROTOPAL: Multicentric study, descritive and longitudinal about opioid
 rotation (or change of administration route) in advanced cancer patients

 J.G. Barboteo (Spain)
289
 Comparative Study of Pain Assessment, Its Treatments, and Adverse
 Effects of Opioids in Two Palliative Care Centers

 M. Bercovitch (Israel)
290
 Serum cytokines in cancer cachexia
 E. Flamini (Italy)
291
 Palliative sedation: 6 years experience of intermittent en permanent
 sedation for refractory symptoms

 J. Menten (Belgium)
292
 Clinical outcomes in palliative care of cancer cachexia
 D. Tassinari (Italy)
293
 The usage of Morphine sulphate and Morphine hydrochloride
 preparations in treatment of painful malignant ulcers

 S.F. Kazmierczak (Poland)
294
 Experience with methadone in opioid rotation in the treatment of severe
 cancer pain not responsive to morphine or transdermal fentanyl

 W. Leppert (Poland)
295
 Oral transmucosal fentanyl citrate versus immediate release morphine
 in the initial dose finding of transdermal fentanyl treatment

 F. Elsner (Germany)
296
 Antibiotic therapy in Palliative Care
 M. Pestinger (Germany)
297
 The dimension of the holines in context of psychotherapy
 of anxiety in cancer disease

 I. Manolescu (Romania)
298
 Midazolam for acute emesis due to high emetogenic chemotherapy (HEC)
 in patients resistant to desamethasone (DMX) and 5-HT3 antagonists:
 A phase II study

 M. Mandala (Italy)
299
 Symptom Clustering in Advanced Cancer
 D. Walsh (United States)
300
 Facial massage and relaxation for Palliative cancer patients
 A. Visser (Netherlands)
301
 Effects of haptonomic massage for palliative cancer patients treated
 with chemotherapy at a day clinic

 A. Visser (Netherlands)
302
 Erytropoetin (EPO) in palliative cancer care - a clinical follow up
 U. Zachrisson (Sweden)
303
 Efficacy and tolerabilty of zoledronate in patients with
 painful bone metastases

 C. Ripamonti (Italy)
304
 On the role of Fentanyl patch in treating cancer-related pain
 T. Campa (Italy)
305
 The Nutritive support evaluation in tolerance of physical examination
 in patient with congestive heart failure and cardiac cachexia

 G. Aroutiounov (Russia)
306
 Oral Ketamine in Patients with Difficult Cancer Pain Syndromes
 I. Strohscheer (Austria)
307
 Tramadol in the treatment of cancer pain - Polish experience
 W. Leppert (Poland)
308
 Pre-emptive breath-therapy in combination with relaxation-therapy
 at terminal cancer-patients in a hospice

 J. Van Den Broek (Netherlands)
  « back